Sourbha Dani to Risk Assessment
This is a "connection" page, showing publications Sourbha Dani has written about Risk Assessment.
Connection Strength
0.140
-
Makwana B, Khadke S, Kumar A, Nasir K, Wadhera R, Shah R, Sheth S, Kong Y, Navas-Acien A, Adamkiewicz G, Rajagopalan S, Al-Kindi S, Dani SS, Moffatt-Bruce S, Ganatra S. Marine Microplastic Levels and the Prevalence of Cardiometabolic Diseases in US Coastline Counties. J Am Heart Assoc. 2025 Jul; 14(13):e039891.
Score: 0.036
-
Patel H, Sheth A, Nair A, Patel B, Thakkar S, Narasimhan B, Mehta N, Azad Z, Kowlgi GN, Desimone CV, Siontis KC, Dani SS, Labedi MR, Deshmukh AJ. Long-Term Impact of GLP-1 Receptor Agonists on AF Recurrence After Ablation in Obese Patients. J Cardiovasc Electrophysiol. 2025 Aug; 36(8):1808-1816.
Score: 0.036
-
Zordok M, Etiwy M, Abdelazeem M, Dani SS, Tawadros M, Lichaa HT, Kerrigan JL, Basir B, Alaswad K, Miedema M, Brilakis ES, Megaly M. Gender disparity in morbidity and mortality among patients with ST-elevation myocardial infarction due to spontaneous coronary artery dissection complicated by cardiogenic shock. Cardiovasc Revasc Med. 2025 Sep; 78:23-30.
Score: 0.035
-
Khan SU, Dani SS, Ganatra S, Ahmed T, Agalan A, Khadke S, Agarwal S, Zaid S, Arshad HB, Zahid S, Shah AR, Goel SS, Kleiman NS. Percutaneous coronary intervention before transcatheter aortic valve implantation: A propensity score matched analysis. Cardiovasc Revasc Med. 2024 Aug; 65:10-15.
Score: 0.033